TI
ABEO icon

Trexquant Investment’s Abeona Therapeutics ABEO Stock Holding History

Trexquant Investment’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-177,754
Closed -$939K – 1553
2025
Q3 		$939K Buy
177,754
+50,559
+40% +$321K 0.01% 1166
2025
Q2 		$722K Buy
127,195
+7,921
+7% +$45.1K 0.01% 1177
2025
Q1 		$568K Buy
119,274
+50,758
+74% +$276K 0.01% 1246
2024
Q4 		$382K Buy
+68,516
New +$422K ﹤0.01% 1348
2019
Q3 		– Sell
-445
Closed -$53K – 827
2019
Q2 		$53K Buy
+445
New +$74.6K ﹤0.01% 761
2018
Q4 		– Sell
-508
Closed -$163K – 1003
2018
Q3 		$163K Buy
+508
New +$180K 0.01% 853
2018
Q2 		– Sell
-725
Closed -$260K – 857
2018
Q1 		$260K Buy
+725
New +$269K 0.02% 865
2015
Q3 		– Sell
-1,960
Closed -$247K – 999
2015
Q2 		$247K Buy
+1,960
New +$294K 0.03% 870

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Trexquant Investment's ABEO Position: Q4 2025 in Review

Trexquant Investment sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 177,754 shares — an estimated $939K sold.

Trexquant Investment first reported a position in ABEO in Q2 2015 and held it in 8 quarters. The position peaked at $939K in Q3 2025. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Trexquant Investment reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 177,754 Abeona Therapeutics shares in Q4 2025, an estimated $939K.
  • Trexquant Investment first reported a position in Abeona Therapeutics in Q2 2015 and held it in 8 quarters.
  • Trexquant Investment's Abeona Therapeutics position peaked at $939K in Q3 2025.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.